Dec 13, 2022, 10:47 AM by

Dec 13, 2022, 10:00 AM by User Not Found

Bio-IT World | The National Institutes of Health's All of Us Research Program has begun returning personalized health-related DNA results to more than 155,000 participants, with reports detailing whether participants have an increased risk for specific health conditions and how their body might process certain medications.

Dec 13, 2022, 01:00 AM by User Not Found

Bio-IT World | The importance of the pregnancy exposome on health was explored in depth by Barbara Cohn, Ph.D., director and senior research scientist at the Public Health Institute, at the Mayo Clinic’s recent Individualizing Medicine Conference. She has been an integral part of a groundbreaking, multigenerational study examining the ripple effects of chemical exposures on pregnant women and their offspring and the potential for metabolomics to drive individualized prevention and treatment.

Dec 12, 2022, 18:00 PM by

Leading CRDMO implements market-leading platform to streamline its biotherapeutics discovery workflow and data exchange with biopharma customers

Dec 12, 2022, 17:48 PM by

MultiCare Health System is the first to use the Illumicare Trials App in a clinical setting, streamlining clinical trial recruitment and increasing awareness among providers, patients and clinical research teams.

Dec 12, 2022, 17:48 PM by

Digital Therapeutics Alliance and Curebase release publication setting the stage for a fit-for-purpose evidence standard for digital therapeutics (DTx)

Dec 12, 2022, 17:48 PM by

Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury - Company in preparation for formal FDA approval submission

Dec 12, 2022, 17:47 PM by

A new study by scientists at Draper adds to the toolbox researchers can use in understanding the biological processes underway in organ-chips. They discovered a new indicator of toxicity in kidney-chips.

Dec 12, 2022, 17:47 PM by

Scytek Laboratories Inc - The Martius Scarlet Blue (MSB) stain kit is intended for use in the histological demonstration of fibrin, muscle, collagen, and erythrocytes. MSB is a reliable method of differentiating fresh and old fibrin clusters.

Dec 12, 2022, 17:47 PM by

Dec 9, 2022, 10:50 AM by

Endor Labs—a startup taking on the issue of unsecured open source sprawl for healthcare institutions and organizations of every kind – released new research exploring the impact of open source software on supply chain security.

Dec 9, 2022, 10:45 AM by

Leading disease experts and Genomenon published an article titled “Estimation of ENPP1 Deficiency Genetic Prevalence Using a Comprehensive Literature Review and Population Databases” in the Orphanet Journal of Rare Diseases

Dec 9, 2022, 10:44 AM by

Qlucore, a leading provider of powerful visualization-based bioinformatics data analysis tools, announces an upgrade to its Qlucore Omics Explorer (QOE) software. The upgrade adds features and functionality for easier data import and analysis of single cell data.

Dec 9, 2022, 10:43 AM by

Nasdaq First North-listed Qlucore, a leading provider of visualization-based software for research and companion diagnostics, will play an important role as one of five key partners in the OmegaPerMed project. The project aims to optimize treatment with omega-3 to prevent cardiovascular diseases (CVD).

Dec 9, 2022, 01:00 AM by User Not Found

Bio-IT World | Advances in mass spectrometry, ultra-high performance liquid chromatography, and bioinformatics have transformed proteomics research in recent years. The growing power of these technologies has contributed to the widespread application of bottom-up proteomics strategies, based on the characterization of proteins by analysis of peptides released through proteolytic digestion. However, challenges in proteomics data analysis remain, with traditional search strategies limiting the ability to fully interpret data.

Dec 8, 2022, 10:04 AM by

BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for BRM424 in the treatment of neurotrophic keratitis.

Dec 8, 2022, 10:02 AM by

PHASTAR Joins Oncology Development Programme (ODP2) to Accelerate Development of Novel Cancer Innovations London, UK and Durham, NC – 08 December, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO), has joined Lean Life Science’s Oncology Development Programme (ODP2). The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies.

Dec 8, 2022, 09:47 AM by

Partnership seeks to increase clinical trials access, accelerate recruitment, and advance ophthalmic research

Dec 8, 2022, 01:00 AM by User Not Found

Bio-IT World | Last month at the Bio-IT World Conference & Expo Europe, Alexandra Grebe de Barron, senior data product owner, digital transformation & IT, introduced the audience to Bayer’s Real-World Data Store, a human- and machine-friendly self-service shop that facilitates real-world evidence generation across the life-long patient pathway.

Dec 7, 2022, 09:44 AM by

PHASTAR, a global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.